Filing Details
Syra Health Corp (NASDAQ:SYRA) filed a Form 8-K with the Securities and Exchange Commission on August 11, 2026, disclosing a material event.
8k filedNASDAQ:SYRA
Syra Health Corp (SYRA) Reports Material Event to SEC
Syra Health Corp (NASDAQ:SYRA) filed a Form 8-K with the Securities and Exchange Commission on August 11, 2026, disclosing a material event.
At publication ·
What changed
Syra Health Corp (NASDAQ:SYRA) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Syra Health Corp filed a Form 8-K with the SEC on August 11, 2026, disclosing a material event that shareholders should be aware of, though the specific nature of the event is not detailed in this filing notice.
- The company's stock trades at $0.87 per share with a market capitalization of $805.1K, indicating a very small-cap healthcare company.
- Form 8-K filings report material events such as leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance that occur between regular quarterly or annual reports.
Market Context
Syra Health Corp's stock currently trades at $0.87 with a market capitalization of $805.1K. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Syra Health Corp's stock.
All SEC filings for Syra Health Corp are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View SYRA Stock Page
Frequently Asked Questions
Where can I read SYRA's SEC filings?
Browse all filings on our SYRA SEC filings page.
What types of SEC filings does Syra Health Corp file?
Public companies like Syra Health Corp file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.